{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:18:25Z","timestamp":1790018305061,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.euroneuro.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T09:32:51Z","timestamp":1498555971000},"page":"732-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample"],"prefix":"10.1016","volume":"27","author":[{"given":"Amie C.","family":"Hayley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Con","family":"Stough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2017.06.004_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0033291704002545","article-title":"A twin study of early cannabis use and subsequent use and abuse\/dependence of other illicit drugs","volume":"34","author":"Agrawal","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib2","unstructured":"American Psychiatric Association (APA), 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA), 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth edition, Washington.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10550887.2010.509273","article-title":"Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do","volume":"29","author":"Arria","year":"2010","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib6","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.drugalcdep.2014.09.069","article-title":"The effect of marijuana commercialization on adolescent polysubstance use and treatment","volume":"146","author":"Belendiuk","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10826084.2014.958857","article-title":"Perceived harm, addictiveness, and social acceptability of tobacco products and Marijuana among young adults: Marijuana, Hookah, and Electronic Cigarettes Win","volume":"50","author":"Berg","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2014.11.010","article-title":"Recent trends in the availability and use of amphetamine and methamphetamine in Norway","volume":"246","author":"Bramness","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archpsyc.59.11.1039","article-title":"DRug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders","volume":"59","author":"Brook","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib10","unstructured":"Bureau of the Census, 2012.\u00a0American Community Survey Data. Suitland, Maryland."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2004.11.014","article-title":"Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000\u20132001","volume":"79","author":"Chen","year":"2005","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0376-8716(97)00047-1","article-title":"Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States","volume":"46","author":"Chen","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.291.17.2114","article-title":"Prevalence of marijuana use disorders in the united states: 1991\u20131992 and 2001\u20132002","volume":"291","author":"Compton","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fpsyt.2013.00079","article-title":"Polysubstance Use in Cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and Cannabis-related beliefs","volume":"4","author":"Connor","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/09540260902782745","article-title":"Cannabis use disorder: epidemiology and management","volume":"21","author":"Copeland","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0740-5472(00)00148-3","article-title":"Clinical profile of participants in a brief intervention program for cannabis use disorder","volume":"20","author":"Copeland","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00179-9","article-title":"A randomized controlled trial of brief cognitive\u2013behavioral interventions for cannabis use disorder","volume":"21","author":"Copeland","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pbb.2006.12.001","article-title":"Adolescent cortical development: a critical period of vulnerability for addiction","volume":"86","author":"Crews","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0924-9338(99)00234-5","article-title":"Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?","volume":"14","author":"Dalmau","year":"1999","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0376-8716(01)00130-2","article-title":"The relationship between cannabis use and other substance use in the general population","volume":"64","author":"Degenhardt","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2007.07.003","article-title":"Are diagnostic orphans at risk of developing cannabis abuse or dependence?: four-year follow-up of young adult cannabis users not meeting diagnostic criteria","volume":"92","author":"Degenhardt","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib23","doi-asserted-by":"crossref","first-page":"e76635","DOI":"10.1371\/journal.pone.0076635","article-title":"The global epidemiology and contribution of Cannabis use and dependence to the global burden of disease: results from the GBD 2010 Study","volume":"8","author":"Degenhardt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib24","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1002\/sim.3239","article-title":"An imputation strategy for incomplete longitudinal ordinal data","volume":"27","author":"Demirtas","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1360-0443.97.s01.10.x","article-title":"Changing the focus: the case for recognizing and treating cannabis use disorders","volume":"97","author":"Dennis","year":"2002","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib26","series-title":"Applied Missing Data Analysis","author":"Enders","year":"2010"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S003329171400107X","article-title":"Natural course of Cannabis use disorders","volume":"45","author":"Farmer","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2003.00632.x","article-title":"The utility of drug testing in epidemiological research: results from a general population survey","volume":"99","author":"Fendrich","year":"2004","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1360-0443.2000.9545053.x","article-title":"Does cannabis use encourage other forms of illicit drug use?","volume":"95","author":"Fergusson","year":"2000","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1360-0443.2005.01322.x","article-title":"Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis","volume":"101","author":"Fergusson","year":"2006","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugalcdep.2014.07.036","article-title":"Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities","volume":"143","author":"Freisthler","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0899-3289(99)00006-1","article-title":"The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the national longitudinal alcohol epidemiologic survey","volume":"10","author":"Grant","year":"1998","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib33","series-title":"Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)","author":"Grant","year":"2014"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib34","unstructured":"Grant, B.F., Chu, A., Sigman, R., Amsbary, M., Kali, J., Sugawara, Y., Jiao, R., Ren, W., Goldstein, R., 2014b. National Institute on Alcohol Abuse and Alcoholism National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC- III) Source and Accuracy Statement, Rockville, MD."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2014.11.026","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample","volume":"148","author":"Grant","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of dsm-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions\u2013III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/070674370204700606","article-title":"Ecstasy and drug consumption patterns: a Canadian Rave population study","volume":"47","author":"Gross","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 Cannabis use disorder, 2012\u20132013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions\u2013III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib39","first-page":"320","article-title":"Self-reported drug use: results of selected empirical investigations of validity","volume":"167","author":"Hser","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archpsyc.58.7.689","article-title":"An evaluation of drug treatments for adolescents in 4 US cities","volume":"58","author":"Hser","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1360-0443.2011.03720.x","article-title":"The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?","volume":"107","author":"Kaye","year":"2012","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1176\/appi.ajp.160.4.687","article-title":"Specificity of genetic and environmental risk factors for use and abuse\/dependence of Cannabis, Cocaine, Hallucinogens, Sedatives, Stimulants, and Opiates in Male Twins","volume":"160","author":"Kendler","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","article-title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","volume":"87","author":"Kerr","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10519-006-9064-9","article-title":"Relationship between adolescent Marijuana use and young adult illicit drug use","volume":"36","author":"Lessem","year":"2006","journal-title":"Behav. Gen."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-2-3","article-title":"Negative consequences associated with dependence in daily cannabis users","volume":"2","author":"Looby","year":"2007","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/13548500220139386","article-title":"Illicit use of psychostimulants among college students: a preliminary study","volume":"7","author":"Low","year":"2002","journal-title":"Psychol. Health Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.289.4.427","article-title":"Escalation of drug use in early-onset cannabis users vs co-twin controls","volume":"289","author":"Lynskey","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1360-0443.2005.00944.x","article-title":"Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey","volume":"100","author":"McCabe","year":"2005","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.drugpo.2015.01.009","article-title":"Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007\u20132013","volume":"26","author":"Miech","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib50","first-page":"20","article-title":"Respiratory effects of Marijuana and tobacco use in a U.S. Sample","author":"Moore","year":"2004","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00952999709040949","article-title":"Characteristics of dual diagnosis patients admitted to an urban, public psychiatric hospital: an examination of individual, social, and community domains","volume":"23","author":"Mowbray","year":"1997","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib52","unstructured":"National Institute of Alcohol Abuse and Alcoholism (NIAAA), 2014. NESARC-III Data Notes."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-clinpsy-032816-045128","article-title":"Effects of changes in marijuana laws on marijuana use and disorders: medical marijuana and marijuana legalization","volume":"13","author":"Pacula","year":"2017","journal-title":"Ann. Rev. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib54","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1360-0443.2003.00350.x","article-title":"Is there a progression from abuse disorders to dependence disorders?","volume":"98","author":"Ridenour","year":"2003","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2014.04.016","article-title":"Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11","volume":"140","author":"Schuermeyer","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2215-0366(14)70307-4","article-title":"Young adult sequelae of adolescent cannabis use: an integrative analysis","volume":"1","author":"Silins","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib57","unstructured":"SPSS, 2012. IBM SPSS statistics version 21. International Business Machines Corp, Boston, MA."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib58","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1037\/0022-006X.61.6.1100","article-title":"Adult marijuana users seeking treatment","volume":"61","author":"Stephens","year":"1993","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0740-5472(01)00206-9","article-title":"Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS)","volume":"22","author":"Stewart","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2005.03.009","article-title":"Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"80","author":"Stinson","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0033291706008361","article-title":"Cannabis use disorders in the USA: prevalence, correlates and co-morbidity","volume":"36","author":"Stinson","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1360-0443.2009.02829.x","article-title":"The added risk of opioid problem use among treatment-seeking youth with Marijuana and\/or alcohol problem use","volume":"105","author":"Subramaniam","year":"2010","journal-title":"Addict"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib63","unstructured":"Substance Abuse and Mental health Services Admisntration (SAMHSA). Substance Abuse Facilities Data. \u3008https:\/\/www.samhsa.gov\/data\/substance-abuse-facilities-data-nssats\u3009."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jadohealth.2005.02.013","article-title":"Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates","volume":"37","author":"Sung","year":"2005","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0954579499002266","article-title":"Etiology of early age onset substance use disorder: a maturational perspective","volume":"11","author":"Tarter","year":"1999","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archpsyc.55.11.967","article-title":"Co-occurrence of abuse ofy different drugs in men: the role of drug-specific and shared vulnerabilities","volume":"55","author":"Tsuang","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib67","unstructured":"United Nations Office of Drug Control and Crime Prevention (UNODC), 2016. World Drug Report. Oxford University Press; Oxford New York, 43-51. Available at: \u3008http:\/\/www.unodc.org\/doc\/wdr2016\/WORLD_DRUG_REPORT_2016_web.pdf\u3009."},{"key":"10.1016\/j.euroneuro.2017.06.004_bib68","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","article-title":"From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol","volume":"26","author":"Wagner","year":"2002","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2017.06.004_bib69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugalcdep.2006.01.002","article-title":"Concurrent Use of Methamphetamine, MDMA, LSD, Ketamine, GHB, and Flunitrazepam among American Youths","volume":"84","author":"Wu","year":"2006","journal-title":"Drug Alcohol Depend."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1730281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1730281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T05:38:48Z","timestamp":1569562728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1730281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924977X1730281X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}